Rocket Pharmaceuticals, Inc. (RCKT) DCF Valuation

Rocket Pharmaceuticals, Inc. (RCKT) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Rocket Pharmaceuticals, Inc. (RCKT) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Rocket Pharmaceuticals, Inc. (RCKT) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Simplifique la valoración de Rocket Pharmaceuticals, Inc. (RCKT) con esta calculadora DCF personalizable! Con Real Rocket Pharmaceuticals, Inc. (RCKT) financieros y entradas de pronóstico ajustables, puede probar escenarios y descubrir Rocket Pharmaceuticals, Inc. (RCKT) valor razonable en minutos.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -71.1 -131.6 -161.7 -213.7 -236.6 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .4 1.1 5.4 6.3 7.1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -71.6 -132.7 -167.1 -220.0 -243.7 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 304.1 482.7 388.7 356.4 373.2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -23.3 -29.1 -7.7 -8.6 -16.5 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -77.1 -139.4 -167.6 -217.5 -243.7 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -99.9 -167.3 -169.9 -219.8 -253.1 .0 .0 .0 .0 .0
WACC, % 9.54 9.54 9.54 9.54 9.54 9.54 9.54 9.54 9.54 9.54
PV UFCF
SUM PV UFCF .0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -31
Equity Value 31
Diluted Shares Outstanding, MM 84
Equity Value Per Share 0.37

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real RCKT financials.
  • Real-World Data: Access to historical data and forward-looking estimates (highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Quickly observe the effect of your inputs on Rocket Pharmaceuticals' valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • 🔍 Real-Life RCKT Financials: Pre-filled historical and projected data for Rocket Pharmaceuticals, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Rocket Pharmaceuticals’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Rocket Pharmaceuticals’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Rocket Pharmaceuticals, Inc. (RCKT) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including Rocket Pharmaceuticals, Inc. (RCKT) intrinsic value.
  • Step 5: Utilize the outputs to make informed investment decisions or create reports.

Why Choose Rocket Pharmaceuticals, Inc. (RCKT)?

  • Innovative Solutions: Cutting-edge therapies aimed at transforming patient outcomes.
  • Expertise in Gene Therapy: A strong focus on developing advanced genetic treatments for rare diseases.
  • Commitment to Quality: Rigorous standards ensure the highest level of safety and efficacy in our products.
  • Strong Pipeline: A diverse range of promising candidates in various stages of development.
  • Backed by Research: Collaborations with leading institutions enhance our scientific credibility.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Rocket Pharmaceuticals stock (RCKT).
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Rocket Pharmaceuticals.
  • Consultants: Deliver professional valuation insights on Rocket Pharmaceuticals to clients quickly and accurately.
  • Business Owners: Understand how biopharmaceutical companies like Rocket Pharmaceuticals are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Rocket Pharmaceuticals.

What the Template Contains

  • Historical Data: Includes Rocket Pharmaceuticals' past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Rocket Pharmaceuticals' intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Rocket Pharmaceuticals' financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.